IMS Health - History and Acquisitions

History and Acquisitions

The original name of the company was Intercontinental Medical Statistics, hence the IMS moniker. IMS Health's corporate headquarters is located in Danbury, Connecticut. The company's chairman and chief executive officer is Ari Bousbib.

• In 2002, IMS acquired Cambridge Pharma Consultancy, a privately held international firm that provides strategic advice to senior pharmaceutical management.
• In 2003, the company acquired Marketing Initiatives, a specialist in healthcare facility profile data, and Data Niche Associates, a provider of rebate validation services for Medicaid and managed care.
• In 2004, United Research China Shanghai was acquired, providing coverage of China’s consumer health market.
• In 2005, IMS acquired PharMetrics, a U.S. provider of patient-centric integrated claims data.
• In 2006, the company acquired the Life Sciences practice of Strategic Decisions Group, a portfolio strategy consultant to the life sciences industry.
• In 2007, IMS acquired IHS and MedInitiatives, providers of healthcare data management analytics and technology services. That same year, ValueMedics Research was acquired, extending IMS’s health economics and outcomes research capabilities.
• In 2007, IMS was ranked in The Business Week 50. This list represents "best in class" companies from the ten economic sectors that make up the S&P 500.
• In 2008, IMS is named to the World’s Most Admired Companies list by Fortune (magazine). The company received the recognition again in 2010.
• In 2008, IMS acquired RMBC, a provider of national pharmaceutical market intelligence and analytics in Russia.
• In 2008, IMS acquired the Skura professional services group, based out of Mississauga,ON Canada and specialized in data integration, consulting and services in Business Intelligence platforms to Pharmaceutical and Healthcare clients in North America and Europe.
• In 2009, IMS is named to the Dow Jones Sustainability North America Index in recognition of the company’s economic, environmental and social performance among the largest 600 North American companies.
• In February 2010, IMS Health was taken private by TPG Capital, CPP Investment Board, and Leonard Green & Partners.
• In 2010, IMS acquired Brogan, Inc., a privately held market research and consulting firm serving the Canada healthcare market.
• In 2011, IMS expanded its specialty and patient-level data assets in the U.S. with the acquisition of SDI Health. Also that year, the company acquired Ardentia Ltd in the U.K., and Med-Vantage in the U.S. to build on its payer services in those markets.
• In 2012, IMS acquired PharmARC Analytic Solutions Pvt. Ltd, a Bangalore based analytic services company.
• For 2012, IMS Consulting Group was rated as #2 in Vault's 'Pharmaceutical & Healthcare Consulting Companies' 2012 rankings.
• In 2012, IMS Health acquired DecisionView, a software solutions company that helps life sciences organizations plan and track patient enrollment for clinical trials and TTC, a benchmarking solutions and analytics company that helps clients plan for and negotiate the costs of clinical trials. Also in 2012, the company purchased PharmaDeals Ltd., a provider of online information about business transactions, licensing, and mergers & acquisitions activity within the pharmaceutical industry.